Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.

Fertig JB, Ryan ML, Falk DE, Litten RZ, Mattson ME, Ransom J, Rickman WJ, Scott C, Ciraulo D, Green AI, Tiouririne NA, Johnson B, Pettinati H, Strain EC, Devine E, Brunette MF, Kampman K, A Tompkins D, Stout R; NCIG 002 Study Group.

Alcohol Clin Exp Res. 2012 Aug;36(8):1421-30. doi: 10.1111/j.1530-0277.2011.01716.x. Epub 2012 Feb 10.

2.

Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.

Mbizvo GK, Dixon P, Hutton JL, Marson AG.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD001901. doi: 10.1002/14651858.CD001901.pub2. Review.

PMID:
22972056
3.

Spotlight on levetiracetam in epilepsy.

Lyseng-Williamson KA.

CNS Drugs. 2011 Oct 1;25(10):901-5. doi: 10.2165/11208340-000000000-00000. Review.

PMID:
21936590
4.

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.

Pettinati HM, O'Brien CP, Rabinowitz AR, Wortman SP, Oslin DW, Kampman KM, Dackis CA.

J Clin Psychopharmacol. 2006 Dec;26(6):610-25. Review.

PMID:
17110818
5.

Anticonvulsants for fibromyalgia.

Üçeyler N, Sommer C, Walitt B, Häuser W.

Cochrane Database Syst Rev. 2013 Oct 16;(10):CD010782. doi: 10.1002/14651858.CD010782. Review.

PMID:
24129853

Supplemental Content

Support Center